Trygg Pharma AS – a company that will be jointly owned by Aker BioMarine ASA and an affiliate of Lindsay Goldberg LLC through a newly established joint venture company (cf. the separate notice of today) – has entered into an agreement to acquire 100% of the shares in Epax Holding AS (together with its subsidiaries “Epax”), a wholly owned subsidiary of Austevoll Seafood ASA. Epax is the world’s premier high concentrate omega-3 supplement manufacturer. Epax employs a total of 74 people.
In July 2013, FMC Corporation acquired Epax Nutra Holding III AS (Norway) and Epax UK Holding III AS (United Kingdom) (together, Epax)
Vietnam's Tuna Exports in November Fall Short of Expectations Viet Nam
Vietnam's tuna exports in November 2024 failed to sustain the rapid growth momentum seen earlier in the year. The export value for the month reached nearly $82 million, marking an increase of just...
Trygg Pharma AS
Personal Profile
Shareholder companies:
Print
